Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage/Experiment 1/Signature 2
From BugSigDB
< Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage | Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage/Experiment 1
Reviewed Marked as Reviewed by Fatima on 2022/09/7
Source: Table 2, Figure 2B, text
Description: Comparison of the distribution of gut microbiota between the metronomic group and the routine group at different levels.
Abundance in Group 1: decreased abundance in responders (patients treated with metronomic dose of capecitabine)
| NCBI | Quality Control | Links |
|---|---|---|
| Blautia | ||
| Cyanobacteriota | ||
| Streptophyta | ||
| Blautia sp. |
